Table 5.
Relationship between HTN control and selected risk factors after adjustment for confounding factors.
| Variables | Category | Hypertension | Odds ratio | CI | P value∗∗ | |
|---|---|---|---|---|---|---|
| Uncontrolled | Controlled | |||||
| Diabetes | Diabetic | 83 (69.2%) | 37 (30.8%) | 1.905 | 1.093–3.318 | 0.010 |
| Nondiabetic | 53 (54.1%) | 45 (45.9%) | ||||
|
| ||||||
| BMI (kg/m2) | ≥30 | 56 (70.9%) | 23 (29.1%) | 2.451 | 1.145–5.247 | 0.009 |
| 25–30 | 66 (61.7%) | 41 (38.3%) | ||||
| ≤25 | 14 (43.8%) | 18 (56.2%) | ||||
|
| ||||||
| Smoking | Smoker | 49 (75.4%) | 16 (24.6%) | 4.068 | 1.214–4.445 | <0.0001 |
| Nonsmoker | 87 (56.9%) | 66 (43.1%) | ||||
|
| ||||||
| Number of antihypertensive drugs | Mono therapy | 78 (69.1%) | 35 (30.9) | 1.860 | 1.038–3.143 | 0.004 |
| Combination therapy | 58 (55.3%) | 47 (44.7%) | ||||
CI: confidence interval = 95%. ∗∗P value of 0.05 or less was considered statistically significant.